Sonoco launches Envoy Series for refrigerated and CRT shipping applications

Sonoco ThermoSafe, a unit of Sonoco (NYSE: SON) and a leading global provider of temperature assurance packaging, has added frozen (less than minus 20 degrees Celsius) configurations to its popular Envoy Series of pre-qualified shippers. The Envoy Series is a proven solution for maintaining pharmaceuticals, biologics, vaccines and other high-value products within a specified temperature range during transport.  With the addition of the frozen range, the Envoy Series now offers a complete suite of solutions for frozen, refrigerated and CRT shipping applications.

"The addition of frozen configurations to the Envoy Series now gives Sonoco ThermoSafe Europe one of the most comprehensive selections of temperature controlled shippers available," said Niall Lehane, general manager, Sonoco ThermoSafe Europe. "We will continue to expand the Envoy line by adding sizes and durations as needed to meet market and regulatory requirements."

Russell Grissett, Sonoco ThermoSafe division vice president, commented, "Our presence in Europe is now stronger than ever with our added manufacturing capability in Germany and the availability of the full Envoy series. We will continue adding innovative products to our portfolio in Europe to address the ever-changing needs of the market."

The Envoy Frozen Series currently consists of four sizes ranging from 2.5 litres to 24 litres.  The shippers will maintain the payload's temperature at less than minus 20 degrees Celsius for a minimum of four days, depending on model. All Envoy shipping systems are pre-qualified to our real world ISCsilver® ambient profile to ensure compliance to GDP regulations.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FORT-2 trial shows promising results for bladder cancer immunotherapy combination